Founded in 2020, Novocardia is the value-based care division of Cardiovascular Associates of America (CVAUSA), a comprehensive cardiology practice management services organization working with more than 450 cardiovascular clinicians across sixteen practices in eight states. These clinicians collectively care for more than 750,000 patients. Novocardia is dedicated to developing and testing value-based care and contracting models and scaling them across the CVAUSA network--accelerating its clinicians’ ability to deliver the right care, in the right place, at the right time, for all Americans with cardiovascular disease.
Novocardia | Taking on Risk with Data-Backed Confidence
Value-Based Contracting
Customer Stories
Performance Evaluation
Value-Based Care
Cardiovascular Health
September 28, 2023
.jpg)
Industry
Value-based cardiovascular care
Use Case
Performance measurement, Contract reconciliation
Challenge
Reconciling contracts for a complex and varied population. The cardiology patient population is highly variable in spend and clinical severity, so taking risk on this population necessitates a reconciliation process that accounts for risk adjustment based on a range of factors.
Solution
Creating a customized methodology for assessing Novocardia’s performance.
Accorded and Novocardia co-developed a performance measurement methodology that details the necessary calculations and steps required to reconcile a value-based contract with Novocardia. Accorded was responsible for designing the calculations to determine payer mix and case mix adjustment factors.
Impact
Taking on risk with data-backed confidence. With a rigorous performance measurement methodology that accounts for multiple risk adjustment factors, Novocardia can enter risk-based contracts with greater confidence and peace of mind.
To learn more about Novocardia, visit cvausa.com/novocardia or email info@cvausa.com.
Back to Blog
.jpg)
.jpg)
.jpg)
